AAAAAA
Results:
1-11
|
Results: 11
Authors:
Mendelman, PM
Cordova, J
Cho, I
Citation: Pm. Mendelman et al., Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults, VACCINE, 19(17-19), 2001, pp. 2221-2226
Authors:
Luce, BR
Zangwill, KM
Palmer, CS
Mendelman, PM
Yan, LH
Wolff, MC
Cho, IS
Marcy, SM
Iacuzio, D
Belshe, RB
Citation: Br. Luce et al., Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children, PEDIATRICS, 108(2), 2001, pp. NIL_22-NIL_29
Authors:
Lee, MS
Greenberg, DP
Yeh, SH
Yogev, R
Reisinger, KS
Ward, JI
Blatter, MM
Cho, I
Holmes, SJ
Cordova, JM
August, MJ
Chen, W
Mehta, HB
Coelingh, KL
Mendelman, PM
Citation: Ms. Lee et al., Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccinationand human PIV3 infection in young infants, J INFEC DIS, 184(7), 2001, pp. 909-913
Authors:
Lee, MS
Mendelman, PM
Sangli, C
Cho, IS
Mathie, SL
August, MJ
Citation: Ms. Lee et al., Half-life of human parainfluenza virus type 3 (hPIV3) maternal antibody and cumulative proportion of hPIV3 infection in young infants, J INFEC DIS, 183(8), 2001, pp. 1281-1284
Authors:
Blum, MD
Dagan, R
Mendelman, PM
Pinsk, V
Giordani, M
Li, S
Bohidar, N
McNeely, TB
Citation: Md. Blum et al., A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers, VACCINE, 18(22), 2000, pp. 2359-2367
Authors:
Longini, IM
Halloran, ME
Nizam, A
Wolff, M
Mendelman, PM
Fast, PE
Belshe, RB
Citation: Im. Longini et al., Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control, VACCINE, 18(18), 2000, pp. 1902-1909
Authors:
Cha, TA
Kao, K
Zhao, J
Fast, PE
Mendelman, PM
Arvin, A
Citation: Ta. Cha et al., Genotypic stability of cold-adapted influenza virus vaccine in an efficacyclinical trial, J CLIN MICR, 38(2), 2000, pp. 839-845
Authors:
Belshe, RB
Gruber, WC
Mendelman, PM
Cho, I
Reisinger, K
Block, SL
Wittes, J
Iacuzio, D
Piedra, P
Treanor, J
King, J
Kotloff, K
Bernstein, DI
Hayden, FG
Zangwill, K
Yan, LH
Wolff, M
Citation: Rb. Belshe et al., Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine, J PEDIAT, 136(2), 2000, pp. 168-175
Authors:
Belshe, RB
Gruber, WC
Mendelman, PM
Mehta, HB
Mahmood, K
Reisinger, K
Treanor, J
Zangwill, Z
Hayden, FG
Bernstein, DI
Kotloff, K
King, J
Piedra, PA
Block, SL
Yan, LH
Wolff, M
Citation: Rb. Belshe et al., Correlates of immune protection induced by live, attenuated, cold-adapted,trivalent, intranasal influenza virus vaccine, J INFEC DIS, 181(3), 2000, pp. 1133-1137
Authors:
Jackson, LA
Holmes, SJ
Mendelman, PM
Huggins, L
Cho, I
Rhorer, J
Citation: La. Jackson et al., Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist (TM), administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions, VACCINE, 17(15-16), 1999, pp. 1905-1909
Authors:
Nichol, KL
Mendelman, PM
Mallon, KP
Jackson, LA
Gorse, GJ
Belshe, RB
Glezen, WP
Wittes, J
Citation: Kl. Nichol et al., Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults - A randomized controlled trial, J AM MED A, 282(2), 1999, pp. 137-144
Risultati:
1-11
|